Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
  		Contents: Volume 19, Supplement 7, September 2008   [Index by Author] 

Down Articles
Down educational sessions
     Lung cancer: new opportunities
     Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer?
     Multimodality treatment in locoregional gynecological cancer: State-of-the-art
     Advanced prostate cancer
     Challenges in treating older cancer patients
     New developments in myeloma
     Important issues in supportive care
     State-of-the-art approach in selective curable tumors
     Introducing new molecular technologies into routine clinical cancer care
     Optimizing approaches to head and neck cancer
     Management of glioma
     Clinical cancer control and prevention
     Recent progress in immunotherapy
     Progress in the multidisciplinary treatment of GI cancers, impact on clinical practice
     Challenge Your Expert sessions

 
Educational Book of the 33rd ESMO Congress Stockholm, Sweden 12-16 September 2008

Guest Editors: ESMO Educational Committee

[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF) | Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles Back

ESMO Education
Ann Oncol 2008 19: vii5-vii7; doi:10.1093/annonc/mdn432 [PDF] [Request Permissions]  

ESMO-MORA
Ann Oncol 2008 19: vii8-vii9; doi:10.1093/annonc/mdn580 [PDF] [Request Permissions]  

ESMO Educational and Scientific activites
Ann Oncol 2008 19: vii10-vii12; doi:10.1093/annonc/mdn581 [PDF] [Request Permissions]  

ESMO Fellowship Program
Ann Oncol 2008 19: vii13-vii15; doi:10.1093/annonc/mdn582 [PDF] [Request Permissions]  

Young Oncologists
Ann Oncol 2008 19: vii16; doi:10.1093/annonc/mdn583 [PDF] [Request Permissions]  

European Society for Medical Oncology Committees
Ann Oncol 2008 19: vii17-vii18; doi:10.1093/annonc/mdn584 [PDF] [Request Permissions]  

33rd ESMO Congress Officers
Ann Oncol 2008 19: vii19-vii20; doi:10.1093/annonc/mdn593 [PDF] [Request Permissions]  

33rd ESMO Congress Organization
Ann Oncol 2008 19: vii21; doi:10.1093/annonc/mdn585 [PDF] [Request Permissions]  

Rolf A. Stahel
Introduction
Ann Oncol 2008 19: vii22; doi:10.1093/annonc/mdn586 [PDF] [Request Permissions]  

educational sessions Back

Lung cancer: new opportunities Back

P. E. Postmus
Screening for lung cancer, an ongoing debate
Ann Oncol 2008 19: vii25-vii27; doi:10.1093/annonc/mdn464 [PDF] [Request Permissions]  

W. Weder
Lung cancer: new opportunities—changing algorithm in staging
Ann Oncol 2008 19: vii28-vii30; doi:10.1093/annonc/mdn480 [PDF] [Request Permissions]  

A. Rajan, M. Gutierrez, and G. Giaccone
Newer opportunities in systemic therapy of lung cancer
Ann Oncol 2008 19: vii31-vii37; doi:10.1093/annonc/mdn445 [PDF] [Request Permissions]  

Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? Back

T. Cufer
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? • The 2007 St Gallen guidelines and/or Adjuvant! Online
Ann Oncol 2008 19: vii41-vii45; doi:10.1093/annonc/mdn439 [PDF] [Request Permissions]  

P. Dinh and C. Sotiriou
Treatment tailoring based on molecular characterizations
Ann Oncol 2008 19: vii46-vii50; doi:10.1093/annonc/mdn472 [PDF] [Request Permissions]  

I. E. Smith
Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? • Treatment decision-making in advanced disease
Ann Oncol 2008 19: vii51-vii57; doi:10.1093/annonc/mdn453 [PDF] [Request Permissions]  

Multimodality treatment in locoregional gynecological cancer: State-of-the-art Back

P. A. Vasey
Ovarian cancer: front-line standard treatment in 2008
Ann Oncol 2008 19: vii61-vii66; doi:10.1093/annonc/mdn479 [PDF] [Request Permissions]  

N. Reed
Endometrial cancer: adjuvant treatment of endometrial cancer—radiotherapy, chemotherapy or both
Ann Oncol 2008 19: vii67-vii69; doi:10.1093/annonc/mdn467 [PDF] [Request Permissions]  

A. Poveda and A. Gonzalez-Martin
Multimodality treatment in locoregional gynecological cancer: cervical cancer treatment update
Ann Oncol 2008 19: vii70-vii76; doi:10.1093/annonc/mdn465 [PDF] [Request Permissions]  

Advanced prostate cancer Back

B. Seruga and I. F. Tannock
The changing face of hormonal therapy for prostate cancer
Ann Oncol 2008 19: vii79-vii85; doi:10.1093/annonc/mdn477 [PDF] [Request Permissions]  

M. R. Smith
Treament-related diabetes and cardiovascular disease in prostate cancer survivors
Ann Oncol 2008 19: vii86-vii90; doi:10.1093/annonc/mdn458 [PDF] [Request Permissions]  

C. N. Sternberg
Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer
Ann Oncol 2008 19: vii91-vii95; doi:10.1093/annonc/mdn473 [PDF] [Request Permissions]  

Challenges in treating older cancer patients Back

H. Wildiers
Challenges in treating older cancer patients: breast cancer
Ann Oncol 2008 19: vii99-vii103; doi:10.1093/annonc/mdn481 [PDF] [Request Permissions]  

D. Papamichael
Challenges in treating older cancer patients: colon cancer
Ann Oncol 2008 19: vii104-vii108; doi:10.1093/annonc/mdn463 [PDF] [Request Permissions]  

C. Gridelli, A. Rossi, and P. Maione
Challenges treating older non-small cell lung cancer patients
Ann Oncol 2008 19: vii109-vii113; doi:10.1093/annonc/mdn448 [PDF] [Request Permissions]  

New developments in myeloma Back

J. Bladé, L. Rosiñol, and M. T. Cibeira
Prognostic factors for multiple myeloma in the era of novel agents
Ann Oncol 2008 19: vii117-vii120; doi:10.1093/annonc/mdn437 [PDF] [Request Permissions]  

M. A. Dimopoulos and E. Kastritis
The role of novel drugs in multiple myeloma
Ann Oncol 2008 19: vii21-vii27; doi:10.1093/annonc/mdn444 [PDF] [Request Permissions]  

J. -L. Harousseau
Autologous transplantation for multiple myeloma
Ann Oncol 2008 19: vii128-vii133; doi:10.1093/annonc/mdn449 [PDF] [Request Permissions]  

Important issues in supportive care Back

M. Dicato
Erythropoetic-stimulating agents: where do we stand?
Ann Oncol 2008 19: vii137-vii140; doi:10.1093/annonc/mdn443 [PDF] [Request Permissions]  

P. Niscola, L. Scaramucci, C. Romani, L. Cupelli, A. Tendas, T. Dentamaro, M. Ales, M. Giovannini, D. Piccioni, B. Tolu, M. Giovannini, A. Perrotti, D. Keefe, and P. de Fabritiis
Mucositis in the treatment of haematological malignancies
Ann Oncol 2008 19: vii141-vii145; doi:10.1093/annonc/mdn462 [PDF] [Request Permissions]  

E. Elez, T. Macarulla, and J. Tabernero
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours
Ann Oncol 2008 19: vii146-vii152; doi:10.1093/annonc/mdn476 [PDF] [Request Permissions]  

State-of-the-art approach in selective curable tumors Back

S. S. Bielack and D. Carrle
State-of-the-art approach in selective curable tumors: bone sarcoma
Ann Oncol 2008 19: vii155-vii160; doi:10.1093/annonc/mdn436 [PDF] [Request Permissions]  

G. Rustin and F. Rehman
State-of-the-art approach in selective curable tumors: germ cell tumors
Ann Oncol 2008 19: vii161-vii165; doi:10.1093/annonc/mdn468 [PDF] [Request Permissions]  

I. Judson
State-of-the-art approach in selective curable tumours: soft tissue sarcoma
Ann Oncol 2008 19: vii166-vii169; doi:10.1093/annonc/mdn454 [PDF] [Request Permissions]  

Introducing new molecular technologies into routine clinical cancer care Back

J. Mackay, H. Haggertay, and A. Pithers
Introducing new molecular technologies into routine clinical cancer care. What new technology and what for?
Ann Oncol 2008 19: vii173-vii176; doi:10.1093/annonc/mdn457 [PDF] [Request Permissions]  

G. Bianchini and L. Gianni
Introducing new molecular technologies into routine clinical cancer care: is there an impact on the treatment of breast cancer?
Ann Oncol 2008 19: vii177-vii183; doi:10.1093/annonc/mdn446 [PDF] [Request Permissions]  

E. C. Johnstone and D. J. Kerr
What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
Ann Oncol 2008 19: vii184-vii186; doi:10.1093/annonc/mdn455 [PDF] [Request Permissions]  

Optimizing approaches to head and neck cancer Back

A. Psyrri and S. Tsiodras
Optimizing approaches to head-and-neck cancers • Viruses in head-and-neck cancers: prevention and therapy
Ann Oncol 2008 19: vii189-vii194; doi:10.1093/annonc/mdn466 [PDF] [Request Permissions]  

J. Giralt, S. Benavente, and M. Arguis
Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease
Ann Oncol 2008 19: vii195-vii190; doi:10.1093/annonc/mdn447 [PDF] [Request Permissions]  

L. Licitra, L. D. Locati, and P. Bossi
Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options
Ann Oncol 2008 19: vii200-vii203; doi:10.1093/annonc/mdn456 [PDF] [Request Permissions]  

Management of glioma Back

K. Herholz
Imaging in glioma
Ann Oncol 2008 19: vii207-vii208; doi:10.1093/annonc/mdn451 [PDF] [Request Permissions]  

R. Stupp, A. F. Hottinger, M. J. van den Bent, P. -Y. Dietrich, and A. A. Brandes
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers
Ann Oncol 2008 19: vii209-vii216; doi:10.1093/annonc/mdn474 [PDF] [Request Permissions]  

B. G. Baumert, and R. Stupp On behalf of the European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology and Brain Tumor Groups
Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy
Ann Oncol 2008 19: vii217-vii222; doi:10.1093/annonc/mdn434 [PDF] [Request Permissions]  

Clinical cancer control and prevention Back

M. Puntoni, D. Marra, S. Zanardi, and A. Decensi
Inflammation and cancer prevention
Ann Oncol 2008 19: vii225-vii229; doi:10.1093/annonc/mdn442 [PDF] [Request Permissions]  

D. W. Bettcher and L. S. Sanda
Clinical cancer control and prevention. Eliminating tobacco-induced cancers: a worldwide challenge
Ann Oncol 2008 19: vii230-vii233; doi:10.1093/annonc/mdn435 [PDF] [Request Permissions]  

H. J. Senn and R. Morant
Chemoprevention of breast and prostate cancers: where do we stand?
Ann Oncol 2008 19: vii234-vii237; doi:10.1093/annonc/mdn470 [PDF] [Request Permissions]  

Recent progress in immunotherapy Back

K. Widén, F. Mozaffari, A. Choudhury, and H. Mellstedt
Overcoming immunosuppressive mechanisms
Ann Oncol 2008 19: vii241-vii247; doi:10.1093/annonc/mdn459 [PDF] [Request Permissions]  

A. G. Dalgleish
Recent progress in immunotherapy: anti-cancer vaccines, emerging clinical data
Ann Oncol 2008 19: vii248-vii251; doi:10.1093/annonc/mdn441 [PDF] [Request Permissions]  

H. Zwierzina
Combining immunotherapy with classical anticancer therapy
Ann Oncol 2008 19: vii252-vii255; doi:10.1093/annonc/mdn482 [PDF] [Request Permissions]  

Progress in the multidisciplinary treatment of GI cancers, impact on clinical practice Back

A. Okines and D. Cunningham
Progress in the multidisciplinary treatment of gastrointestinal cancers, impact on clinical practice: peri-operative management of gastro-esophageal cancer
Ann Oncol 2008 19: vii259-vii265; doi:10.1093/annonc/mdn440 [PDF] [Request Permissions]  

A. Cervantes, S. Roselló, E. Rodríguez-Braun, S. Navarro, S. Campos, A. Hernández, and E. García-Granero
Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer
Ann Oncol 2008 19: vii266-vii272; doi:10.1093/annonc/mdn438 [PDF] [Request Permissions]  

V. Heinemann and S. Boeck
Perioperative management of pancreatic cancer
Ann Oncol 2008 19: vii273-vii278; doi:10.1093/annonc/mdn450 [PDF] [Request Permissions]  

Challenge Your Expert sessions Back

J. Baselga
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed?
Ann Oncol 2008 19: vii281-vii288; doi:10.1093/annonc/mdn433 [PDF] [Request Permissions]  

J. B. Hopkinson, D. N. M. Wright, and C. Foster
Management of weight loss and anorexia
Ann Oncol 2008 19: vii289-vii293; doi:10.1093/annonc/mdn452 [PDF] [Request Permissions]  

F. O. B. Spoelstra and S. Senan
Novel tools in radiotherapy
Ann Oncol 2008 19: vii294-vii299; doi:10.1093/annonc/mdn469 [PDF] [Request Permissions]  

C. Terret
How and why to perform a geriatric assessment in clinical practice
Ann Oncol 2008 19: vii300-vii303; doi:10.1093/annonc/mdn478 [PDF] [Request Permissions]  

M. J. Moore
The treatment of advanced pancreatic cancer: current evidence and future challenges
Ann Oncol 2008 19: vii304-vii308; doi:10.1093/annonc/mdn461 [PDF] [Request Permissions]  

E. F. Smit
Thymic malignancies
Ann Oncol 2008 19: vii309-vii312; doi:10.1093/annonc/mdn471 [PDF] [Request Permissions]  

T. D. Szucs and K. J. Dedes
Balancing costs and benefits in cancer therapy and prevention
Ann Oncol 2008 19: vii313-vii319; doi:10.1093/annonc/mdn475 [PDF] [Request Permissions]  

E. Montserrat and C. Moreno
Chronic lymphocytic leukaemia: a short overview
Ann Oncol 2008 19: vii320-vii325; doi:10.1093/annonc/mdn460 [PDF] [Request Permissions]  

33rd ESMO Congress Officers
Ann Oncol 2008 19: vii326; doi:10.1093/annonc/mdn587 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.